What is global nanomedicine market?

global nanomedicine market is segmented into drug delivery, diagnostic imaging, tissue regeneration, biomaterials, oncology, and others.

How many nanomedicines are on the market?

To date, there are 100 nanomedicines on the market, and 563 in clinical process or other stages (663 in total). Most of these nanomedicines (Fig. 2A) are in clinical phase I (33%) and phase II (21%), and mainly focus on cancer (53%) and infection (14%) treatments.

What is the market value of Nanomedicine market?

In 2022, the global nanomedicine market was valued at US$ 139 billion. Between 2023 and 2032, this market is estimated to register the highest CAGR of 10.2%.

Global Nanomedicine Market By Molecule Type (Nanoparticles, Nano Tubes, Nano Shells, and Nano Devices), By Indication (Clinical Oncology, Orthopedics, Clinical Cardiology, Infectious Diseases, and Other Indications), By Application, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Nov 2023
Report ID: 36341
Number of Pages: 224
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- Abbott Laboratories
- Teva Pharmaceutical Industries Ltd.
- Nanospectra Biosciences, Inc.
- Celgene Corporation
- CombiMatrix Corporation
- Arrowhead Pharmaceuticals, Inc.
- Pfizer Inc.
- Merck & Co., Inc.
- Mallinckrodt Pharmaceuticals
- Other Key Players